RCMT Stock Recent News
RCMT LATEST HEADLINES
Zacks.com users have recently been watching RCM Technologies (RCMT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
RCM Technologies, Inc. (RCMT) concluded the recent trading session at $22.14, signifying a -3.86% move from its prior day's close.
In the latest trading session, RCM Technologies, Inc. (RCMT) closed at $22.60, marking a -1.18% move from the previous day.
RCM Technologies (RCMT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Recently, Zacks.com users have been paying close attention to RCM Technologies (RCMT). This makes it worthwhile to examine what the stock has in store.
RCM Technologies (RCMT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
RCM Technologies, Inc. (NASDAQ:RCMT ) Q1 2025 Results Conference Call May 8, 2025 10:30 AM ET Company Participants Kevin Miller - Chief Financial Officer Brad Vizi - Executive Chairman Conference Call Participants Liam Burke - B. Riley Securities Kevin Miller Good morning, and thank you for joining us.
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $IIIV--i3 Verticals, Inc. (“i3 Verticals” or the “Company”) (NASDAQ: IIIV), and Infinx, Inc. (“Infinx”), a leader in AI-powered revenue cycle management solutions, today announced the entry into a definitive agreement and the contemporaneous closing of the sale of i3 Verticals' Healthcare Revenue Cycle Management (“RCM”) business, including its associated proprietary technology, to Infinx, in an all-cash transaction for $96 million, subject to post-closing purchase p.
RCM Technologies, Inc. (RCMT) closed the most recent trading day at $17.59, moving -0.9% from the previous trading session.
PENNSAUKEN, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT) will hold a conference call on Thursday, May 8, 2025 at 10:30 a.m. Eastern time to discuss the financial results for the thirteen weeks ended March 29, 2025. The teleconference dial-in numbers are (888) 272-8703 for domestic callers and (713) 936-6995 for international callers.